NOS2 and inflammatory bowel disease: Herein, we demonstrated that the activation of PAR4 in colonic mucosa MCs suppresses their expression of inflammatory mediators, such as tryptase, iNOS, IL-1β, and P2X7, which suggests that these receptors could provide additional important targets for modifying pain in colonic GI disorders, such as IBS and IBD.